Matches in Wikidata for { <http://www.wikidata.org/entity/Q37828260> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q37828260 description "article científic" @default.
- Q37828260 description "article scientifique" @default.
- Q37828260 description "articolo scientifico" @default.
- Q37828260 description "artigo científico" @default.
- Q37828260 description "artículu científicu espublizáu en 2010" @default.
- Q37828260 description "bilimsel makale" @default.
- Q37828260 description "scientific article published on December 2010" @default.
- Q37828260 description "vedecký článok" @default.
- Q37828260 description "vetenskaplig artikel" @default.
- Q37828260 description "videnskabelig artikel" @default.
- Q37828260 description "vědecký článek" @default.
- Q37828260 description "wetenschappelijk artikel" @default.
- Q37828260 description "wissenschaftlicher Artikel" @default.
- Q37828260 description "наукова стаття, опублікована в грудні 2010" @default.
- Q37828260 description "научни чланак" @default.
- Q37828260 description "مقالة علمية نشرت في ديسمبر 2010" @default.
- Q37828260 name "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 name "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 name "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 type Item @default.
- Q37828260 label "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 label "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 label "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 prefLabel "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 prefLabel "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 prefLabel "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 P1433 Q37828260-3424A8E6-B641-4144-9ACB-3DE99B519CFA @default.
- Q37828260 P1476 Q37828260-58C8AD09-EFDB-4321-9F82-8D7EAB2DA85B @default.
- Q37828260 P2093 Q37828260-3AE750B7-8697-4CD9-8A5C-99F225C49A63 @default.
- Q37828260 P2093 Q37828260-5A463B49-FD97-4C9C-AEDB-A177A1CD87E0 @default.
- Q37828260 P2093 Q37828260-C2A03BEE-49A6-48FB-8C96-75AF5DA7FF82 @default.
- Q37828260 P2093 Q37828260-E80233C2-7417-40C7-A1F2-40F479B2BFFF @default.
- Q37828260 P304 Q37828260-D722519D-E80F-4B11-9857-1EFBC546B3BD @default.
- Q37828260 P31 Q37828260-577168A9-E562-4343-B02F-AD87BA68E775 @default.
- Q37828260 P356 Q37828260-3DB57F7C-F3E9-42A0-8471-D776B9C2FF75 @default.
- Q37828260 P407 Q37828260-3E948F2D-69FB-40E5-97E0-79138B52DFCA @default.
- Q37828260 P433 Q37828260-D33B44C6-D1DD-48E5-8100-64A461BFC108 @default.
- Q37828260 P478 Q37828260-C43BEE3B-464A-4D5F-A9FA-E62084F91B23 @default.
- Q37828260 P577 Q37828260-CC768F86-6B42-49EB-AC99-09FA87DE226B @default.
- Q37828260 P5875 Q37828260-85DC734C-5043-4007-A329-5D16E1F97132 @default.
- Q37828260 P698 Q37828260-340DA4F0-3259-4284-AC76-0985B128D819 @default.
- Q37828260 P356 J.JCIN.2010.09.015 @default.
- Q37828260 P698 21232714 @default.
- Q37828260 P1433 Q15816248 @default.
- Q37828260 P1476 "The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes" @default.
- Q37828260 P2093 "Elias B Hanna" @default.
- Q37828260 P2093 "Jorge F Saucedo" @default.
- Q37828260 P2093 "Steven V Manoukian" @default.
- Q37828260 P2093 "Sunil V Rao" @default.
- Q37828260 P304 "1209-1219" @default.
- Q37828260 P31 Q13442814 @default.
- Q37828260 P356 "10.1016/J.JCIN.2010.09.015" @default.
- Q37828260 P407 Q1860 @default.
- Q37828260 P433 "12" @default.
- Q37828260 P478 "3" @default.
- Q37828260 P577 "2010-12-01T00:00:00Z" @default.
- Q37828260 P5875 "49753255" @default.
- Q37828260 P698 "21232714" @default.